ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

WGBS Wafergen Bio-Systems, Inc.

6.90
0.00 (0.00%)
28 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Wafergen Bio-Systems, Inc. NASDAQ:WGBS NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 6.90 7.11 7.10 0 01:00:00

Termination of Registration of a Class of Security Under Section 12(g) (15-12g)

13/03/2017 7:49pm

Edgar (US Regulatory)



 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

FORM 15
 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g ) OF THE SECURITIES EXCHANGE ACT OF 1934
OF SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 000-53252
 

WAFERGEN BIO-SYSTEMS, INC.
(Exact name of registrant as specified in its charter)
 


34700 Campus Drive
Fremont, CA 94555
(510) 651-4450
(Address, including zip code, and telephone number, including area code, of registrants principal executive offices)
Common Stock, $0.001 par value
(Title of each class of securities covered by this Form)


(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
 
 
Rule 12g-4(a)(1)
 
x
 
 
Rule 12g-4(a)(2)
 
¨
 
 
Rule 12h-3(b)(1)(i)
 
x
 
 
Rule 12h-3(b)(1)(ii)
 
¨
 
 
Rule 15d-6
 
¨
 
Approximate number of holders of record as of the certification or notice date: One
 





Pursuant to the requirements of the Securities Exchange Act of 1934, WaferGen Bio-systems, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
 


 
 
 
 
 
 
 
Date: March 13, 2017
 
 
 
By:
 
/s/ Carol Lou
 
 
 
 
Name:
 
Carol Lou
 
 
 
 
Title:
 
President



1 Year WaferGen Bio-Systems, Inc. Chart

1 Year WaferGen Bio-Systems, Inc. Chart

1 Month WaferGen Bio-Systems, Inc. Chart

1 Month WaferGen Bio-Systems, Inc. Chart